poisar

Stocks · News reference

Truist Adjusts Price Target on Elevance Health to $500 From $475

Fiscal.ai

Truist has updated its price target for Elevance Health, increasing it to $500 from the previous $475 while maintaining a Buy rating.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading